RxDoctor Payments Data

Stephen Mock, MD

Urology · Everett, WANPI 1144488503

Payments from drug & device makers

$1,132in general payments, 2019–2025

Across 18 payments — averaging $62.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$269
  • Olympus America Inc.$218
  • Laborie Medical Technologies Corp.$201
  • Pfizer$178
  • Boston Scientific$133
  • Janssen Scientific Affairs, LLC$77
  • plus $56 from 3 others

What the payments were for

  • Food & beverage$1,132100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)4$269
Olympus America Inc.2$218
Laborie Medical Technologies Corp.3$201
Pfizer2$178
Boston Scientific2$133
Janssen Scientific Affairs, LLC1$77
C. R. Bard, Inc. & Subsidiaries2$28
Agiliti Surgical, Inc.1$14
Rochester Medical Corporation1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,132 in reported general payments places this provider in the 40th percentile of 274 urology providers in Washington.

See all urology providers in Washington

Medicare billing

Part B allowed, 2024
$185,149
Medicare patients
408
Services billed
6,352

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron324$226,057
GemtesaVibegron22$17,241
Tamsulosin Hcl476$6,464
Trospium Chloride ErTrospium Chloride23$2,465
Finasteride227$2,366
Estradiol32$2,150
Methenamine Hippurate38$2,123
Solifenacin Succinate67$1,719
Trospium Chloride27$1,389
Oxybutynin Chloride ErOxybutynin Chloride129$1,211
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst66$685
Terazosin Hcl40$663
Alfuzosin Hcl ErAlfuzosin Hcl12$604
Ciprofloxacin Hcl140$427
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen118$427

Paid to pharmacies, not to this prescriber.

Other urology in Everett

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →